美国参议院通过了《林业发展局现代化法》3.0,以推进与人类有关的药物检验方法,减少动物使用和加速发展。 The U.S. Senate passed the FDA Modernization Act 3.0 to advance human-relevant drug testing methods, reducing animal use and speeding development.

美国参议院通过了FDA现代化法案3.0,推进了基于人体细胞和模型的新方法方法 (NAMs) 以实现药物测试的现代化. The U.S. Senate passed the FDA Modernization Act 3.0, advancing new approach methodologies (NAMs) like human cell-based and in silico models to modernize drug testing. 该法律要求FDA为这些方法建立合格途径,旨在提高准确性,减少动物使用,缩短开发时间. The law directs the FDA to establish qualification pathways for these methods, aiming to improve accuracy, reduce animal use, and shorten development times. 瑞士生命科学公司DiNABIOS对这一举动表示欢迎,认为这是朝向提高伦理道德、效率和与人类有关的研究迈出的一大步,强调在采用这些技术时需要科学的严格性和可复制性。 DiNABIOS, a Swiss life science company, welcomed the move as a major step toward more ethical, efficient, and human-relevant research, emphasizing the need for scientific rigor and reproducibility in adopting these technologies.